This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $227.91, moving +1.07% from the previous trading session.
Clorox (CLX) Is Up 3.42% in One Week: What You Should Know
by Zacks Equity Research
Does Clorox (CLX) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Consumer Staple Stocks to Buy With Earnings Beat Potential
by Vrishali Bagree
We have picked five consumer staple stocks, which are likely to report earnings beat this season owing to the burgeoning demand amid the pandemic-led increased at-home consumption.
Is The Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
Here's Why Church & Dwight (CHD) Appears to be Sparkling
by Zacks Equity Research
Church & Dwight (CHD) has been gaining from burgeoning demand amid the pandemic. Also, the company's focus on innovation and buyouts has been aiding.
Why Colgate Stock Should Remain in Investors' Portfolio
by Zacks Equity Research
Colgate (CL) has been one of the beneficiaries of the rise in demand for everyday essentials amid the pandemic.
Zacks.com featured highlights include: T. Rowe Price, The Clorox Company, Lockheed Martin, Xilinx and The Sherwin-Williams Company
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, The Clorox Company, Lockheed Martin, Xilinx and The Sherwin-Williams Company
7 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Factors to Decide the Fate of PepsiCo (PEP) in Q2 Earnings
by Zacks Equity Research
PepsiCo's (PEP) organic revenues for the second quarter are expected to have been marred by uncertainties related to the coronavirus outbreak and higher costs, offset by enhanced digital presence.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $229.50 in the latest trading session, marking a +1.74% move from the prior day.
Clorox (CLX) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Clorox (CLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Why the Earnings Surprise Streak Could Continue for Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 High Dividend-Yielding S&P 500 Stocks Amid Coronavirus Woes
by Swayta Shah
At a time when the coronavirus outbreak has hampered steady stream of income for many, investing in high dividend-yielding stocks can be rewarding. We have picked 5 S&P 500 stocks worth considering.
Clorox (CLX) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Clorox (CLX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
New Strong Buy Stocks For July 2nd
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Clorox (CLX) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Clorox (CLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Clorox (CLX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $219.37 in the latest trading session, marking a +0.82% move from the prior day.
Is The Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
Zacks.com featured highlights include: BWX Technologies, Lowes Companies, State Street, The Clorox Company and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: BWX Technologies, Lowes Companies, State Street, The Clorox Company and T. Rowe Price
The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
5 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Consumer Staples a Safe Bet Amid Economic Woes: 5 Picks
by Ansuiya Mohta
Mounting fears related to higher coronavirus infections have raised vulnerability, making the defensive consumer staple space a safe investment option.
McCormick (MKC) Q2 Earnings Beat Estimates, Sales up
by Zacks Equity Research
McCormick's (MKC) second-quarter 2020 results reflect the impact of higher sales, thanks to coronavirus-led higher at-home consumption.
Procter & Gamble Displays Strength on Demand for Products
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from increased demand for hand soaps, detergents and surface-cleaning products during the pandemic.
Buy 5 Top Consumer Staple Stocks to Minimize Portfolio Risks
by Nalak Das
It will be prudent to invest in consumer staple stocks with a favorable Zacks Rank to minimize portfolio risks.